EN DE
Watch Blinklab Ltd for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Blinklab Ltd (BB1) fair value: what the stock is really worth

As of Nov 19, 2026: fair value (intrinsic value) of Blinklab Ltd stock A$0.35, price A$0.56, that is 36.7% below the price, quality 33 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare AU · ISIN AU0000322851

BL Blinklab Ltd logo Thin data Nov 16, 2026

Blinklab Ltd

BB1 · AU

Far too expensive (fair value 37% below the price), weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Mixed Growth (revenue YoY +916.1 %/yr in AUD) 
Fair value A$0.3515 · Strongly overvalued 
Quality 33/100 
Falling price (downtrend) 
Negative free cash flow 
Trails peers (1/7) 
Narrow moat 6/100 · thin data
Thin data 
Estimate
Watch Blinklab Ltd for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$1.09 A$0.2100 Fair Value A$0.3515 Apr 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

32‑month range A$0.2100 – A$1.09 · fair‑value band A$0.2636 – A$0.4393 · the A$0.5550 price screens above the A$0.3515 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Blinklab in your weekly email

Every Wednesday you see whether Blinklab is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations.

Show moreShow less

The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia.

The company was incorporated in 2021 and is based in Perth, Australia.

Stock analysis

Blinklab Ltd (BB1) currently trades at A$0.5550, while our estimate is A$0.3515, 37% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: A$0.2636 (bear) to A$0.4393 (bull), the price of A$0.5550 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Blinklab Ltd reported revenue of A$376K in FY2025 versus A$0 in FY2022. Reported net income was −A$7.2M in FY2026.

Key figures

Market cap A$97.9M (≈ $65.5M) Micro · P/S ratio 90.5 · EPS (TTM) A$−0.0500 · Return on equity −50.7% · Return on assets (EBIT) −72.1% (5-year average) · Operating margin −319% · Revenue growth (YoY) +387% · Free cash flow −A$7.5M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 49% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −17% fair-value upside, at −37%, BB1 screens richer than that median.

Fair Value

Bear A$0.2636 Fair Value A$0.3515 Bull A$0.4393
Price A$0.5550 · Downside -36.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 33/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 89
Are margins and returns getting better?
Cashflow 2
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 14
How calm the share price moves, does not count
Price momentum 10
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

BB1 screens overvalued: fair value 37% below the price. Compare with Veeva Systems Inc →

Compare Blinklab Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 140 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 33 · Bottom 25%
Fair Value upside −36.7% · Below median
Profitability
Return on assets −35.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 386.5% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 5.02× · Priciest 25%
P/S (12 months) 81.04× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 16
FUTURE (revenue growth)100 · sector 46
PAST (return on equity)0 · sector 3
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 41

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $30.67 $34.22 +12% vs BB1
Veeva Systems Inc VEEV $277.20 $304.92 +10% vs BB1
HealthEquity, Inc HQY $97.31 $107.04 +10% vs BB1
Waystar Holding WAY $27.54 $29.10 +6% vs BB1
Tempus AI, Inc TEM $63.62 $52.58 −17% vs BB1
HeartFlow, Inc HTFL $45.89 $30.50 −34% vs BB1
Hinge Health, Inc HNGE $114.53 $51.25 −55% vs BB1
Pro Medicus Limited PME A$192.55 A$82.80 −57% vs BB1
BrightSpring Health Services, Inc BTSG $68.34 $25.72 −62% vs BB1
Privia Health Group PRVA $24.60 $5.52 −78% vs BB1

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Blinklab Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Blinklab Ltd Fair Value". https://www.fairvalue-calculator.com/stock/BB1

Frequently asked questions

Is Blinklab Ltd (BB1) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is A$0.3515 versus a price of A$0.5550, about 37% lower (overvalued).
What is the fair value of BB1?
Our estimate for Blinklab Ltd is A$0.3515 (as of Nov 16, 2026), built from audited fundamentals. The current price: A$0.5550.
What is the quality score of BB1?
Blinklab Ltd has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Blinklab Ltd (BB1)?
We do not set a price target; the yardstick is our estimate of A$0.3515 (as of Nov 16, 2026). Cautious scenario A$0.2636, optimistic scenario A$0.4393. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Blinklab Ltd stock forecast for 2026?
Our estimate puts fair value at A$0.3515, about 37% lower versus a price of A$0.5550 (overvalued). Cautious scenario A$0.2636, optimistic scenario A$0.4393. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Blinklab Ltd (BB1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Blinklab Ltd it is A$0.3515 per share (as of Nov 16, 2026), against a price of A$0.5550.
Is Blinklab Ltd stock overvalued or undervalued in 2026?
As of Nov 16, 2026, BB1 trades above its calculated fair value: price A$0.5550, fair value A$0.3515, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BB1?
No. The price is what the market pays today (A$0.5550); the fair value is what the company's own numbers justify (A$0.3515). For Blinklab Ltd the two are A$0.2035 per share apart. That gap is exactly why we show both numbers side by side.
How much is Blinklab Ltd worth?
The market values Blinklab Ltd at about A$97.9M (market capitalisation, as of Nov 16, 2026). Per share that is A$0.5550; our models calculate a fair value of A$0.3515 per share.
What do the bullish and bearish scenarios say about BB1?
Our models span a range for Blinklab Ltd: cautious scenario A$0.2636, base A$0.3515, optimistic A$0.4393 per share (as of Nov 16, 2026, price A$0.5550). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Blinklab Ltd (BB1)?
Balance-sheet figures for Blinklab Ltd (as of Nov 16, 2026): return on equity −50.7%. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is BB1 from its 52-week high?
Blinklab Ltd trades at A$0.5550, about 49% below its 52-week high of A$1.09 and at the low of A$0.5550 (as of Nov 19, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.3515 is for.
Which stocks are comparable to Blinklab Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Blinklab Ltd stock attractive at the current price?
The data as of Nov 16, 2026: price A$0.5550, calculated fair value A$0.3515 (−37%), Quality Score 33/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. Blinklab Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Blinklab Ltd (BB1)?
The closing price on Nov 19, 2026 was A$0.5550. Our estimate is A$0.3515, about 37% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Blinklab Ltd right now?
The price sits above even our optimistic bull case (A$0.4393). The favourable scenario is already priced in. Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Blinklab Ltd

How large is the market capitalisation of Blinklab Ltd (BB1)?
The market capitalisation of Blinklab Ltd is A$97.9M (≈ $65.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Blinklab Ltd (BB1)?
The price-to-sales ratio of Blinklab Ltd is 90.5 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Blinklab Ltd (BB1)?
Earnings per share at Blinklab Ltd are A$−0.0500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Blinklab Ltd (BB1)?
The return on equity (ROE) of Blinklab Ltd is −50.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Blinklab Ltd (BB1)?
On an EBIT basis the return on assets of Blinklab Ltd is −72.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Blinklab Ltd (BB1)?
The operating margin of Blinklab Ltd is −319% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Blinklab Ltd (BB1)?
Revenue at Blinklab Ltd is growing 387% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Blinklab Ltd (BB1) generate?
The free cash flow of Blinklab Ltd is −A$7.5M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Blinklab Ltd in the live analysis

One click puts Blinklab Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.